AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Pivotal clinical trial for Intercept Epilepsy Control System begins.

Biotech Week

| May 12, 2004 | COPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 MAY 12 - (NewsRx.com & NewsRx.net) -- Medtronic, Inc., (MDT) announced the start of the U.S. pivotal clinical trial for the Intercept Epilepsy Control System, the company's brain-stimulation therapy that may reduce seizure rates in patients with epilepsy.

"Epilepsy remains a devastating disorder for one-third of patients who don't respond to medications, and brain stimulation may offer new hope for people with uncontrolled epilepsy," said Robert Fisher, MD, PhD, professor of neurology and director of Stanford Epilepsy Center, Stanford University, and principal investigator of the clinical trial. "Pilot studies have been encouraging and this clinical trial, if…

Related articles from newspapers, magazines, journals, and more
Medtronic Announces Start of U.S. Pivotal Clinical Trial for Intercept Epilepsy...
Press release article from: Business Wire April 13, 2004 700+ words
...the U.S. pivotal clinical trial for the Intercept(TM) Epilepsy Control System, the company...investigator of the clinical trial. "Pilot studies have been encouraging and this clinical trial, if successful, will...
Medtronic ''Brain Pacemaker'' Being Studied to Reduce Seizures in Patients with...
Press release article from: Business Wire November 1, 2005 700+ words
...MDT) today announced that the U.S. clinical trial for its Intercept(TM) Epilepsy Control System has met an early milestone...about the trial, or about the Intercept Epilepsy Control System, visit www.epilepsycontrol...
Flame Epilepsy Control Programme formed to check spread of disease.
News wire article from: Asia Africa Intelligence Wire July 26, 2002 700+ words
...Byline: MUHAMMAD SALEEM LAHORE : An NGO, First Liberated Action Movement Against Epilepsy (FLAME), has launched Flame Epilepsy Control Programme (FECP) to wage co-ordinated efforts for controlling the disease of epilepsy which is spreading fast in the...
AVX Tantalum Capacitors Enable Nerve Stimulation for Epilepsy Control.
Press release article from: Business Wire December 30, 1999 700+ words
Business Editors/Medical Writers MYRTLE BEACH, S.CBUSINESS WIREDec. 30, 1999 Epilepsy Patients Offered Control With Nerve Stimulation Device Leading component manufacturer AVX Corporation (NYSE: AVX) announces its presence in state-of-the-art medical technology that improves control of epileptic
Deals roundup.
Magazine article from: Medical Device Week August 8, 2005 700+ words
...physicians and patients manage this condition." Medtronic currently is conducting a pivotal clinical trial in the U.S. for the Intercept Epilepsy Control System, the company's brain stimulation therapy that may reduce seizure rates in epilepsy...
Agreements.
Newspaper article from: The BBI Newsletter September 1, 2005 700+ words
...terms of the agreement were not disclosed. Medtronic currently is conducting a pivotal clinical trial in the U.S. for the Intercept Epilepsy Control System, the company's brain stimulation therapy that may reduce seizure rates in epilepsy...
Medtronic and NeuroPace Ink Cross Licensing Pacts.
Newspaper article from: Wireless News August 6, 2005 700+ words
...physicians and patients manage this condition." Medtronic currently is conducting a pivotal clinical trial in the United States for the Intercept Epilepsy Control System, the company's brain stimulation therapy that may reduce seizure rates in patients...
Medtronic and NeuroPace Cross License Patents for Treating Neurological...
Press release article from: Business Wire August 4, 2005 700+ words
...and patients manage this condition." Medtronic currently is conducting a pivotal clinical trial in the United States for the Intercept(TM) Epilepsy Control System, the company's brain stimulation therapy that may reduce seizure rates...
Medtronic Receives Humanitarian Use Device Designation for Treatment of...
Press release article from: Business Wire March 28, 2005 700+ words
...dystonia (also available under an HDE). Medtronic is currently conducting a pivotal clinical trial in the U.S. for the Intercept(TM) Epilepsy Control System, the company's brain stimulation therapy that may reduce seizure rates in...
Clinical trial websites: a promising tool for improving processes & reducing...
Newspaper article from: Biomedical Market Newsletter Rehnquist, Janet August 31, 2002 700+ words
...PURPOSE To assess the role of clinical trial websites in fostering informed...information on these websites. FINDINGS Clinical trial websites are emerging as an important recruitment strategy. Clinical trial websites are growing in popularity...
For more facts and information, see all results

Source: HighBeam Research, Pivotal clinical trial for Intercept Epilepsy Control System begins.

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily